Chronic loss of inhibitor-1 diminishes cardiac RyR2 phosphorylation despite exaggerated CaMKII activity

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Naunyn-Schmiedeberg's Archives of Pharmacology

• Publication date

  2017-04-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00210-017-1376-1PMID 28451724
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CaMKII as a target for arrhythmia suppression.

  2017cited by this paper
• Active Inhibitor-1 Maintains Protein Hyper-Phosphorylation in Aging Hearts and Halts Remodeling in Failing Hearts

  2013cited by this paper
• Epac in cardiac calcium signaling.

  2013influential reference
• Constitutive phosphorylation of inhibitor-1 at Ser67 and Thr75 depresses calcium cycling in cardiomyocytes and leads to remodeling upon aging

  2012cited by this paper
• Local control of β-adrenergic stimulation: Effects on ventricular myocyte electrophysiology and Ca(2+)-transient.

  2011cited by this paper
• Phosphatase-1 inhibitor-1 in physiological and pathological β-adrenoceptor signalling.

  2011cited by this paper
• CaMKII in myocardial hypertrophy and heart failure.

  2011cited by this paper
• Constitutively active phosphatase inhibitor-1 improves cardiac contractility in young mice but is deleterious after catecholaminergic stress and with aging.

  2010cited by this paper
• Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology.

  2009cited by this paper
• Inducible Expression of Active Protein Phosphatase-1 Inhibitor-1 Enhances Basal Cardiac Function and Protects Against Ischemia/Reperfusion Injury

  2009cited by this paper
• Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy.

  2008cited by this paper
• Role of calcineurin and protein phosphatase-2A in the regulation of phosphatase inhibitor-1 in cardiac myocytes.

  2006cited by this paper
• CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy.

  2006cited by this paper
• Enhancement of Cardiac Function and Suppression of Heart Failure Progression By Inhibition of Protein Phosphatase 1

  2005cited by this paper
• Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts.

  2004cited by this paper
• Evidence for protein phosphatase inhibitor‐1 playing an amplifier role in β‐adrenergic signaling in cardiac myocytes

  2003cited by this paper
• Type 1 Phosphatase, a Negative Regulator of Cardiac Function

  2002cited by this paper
• Protein Phosphatase-1 Regulation in the Induction of Long-Term Potentiation: Heterogeneous Molecular Mechanisms

  2000cited by this paper

• 2-Aminoethoxydiphenyl borate induces arrhythmias via Cx43-S282 dephosphorylation.

  2025cites this paper
• The cardiotropic properties of ZMEI-3 compound – a potential inhibitor of Epac proteins

  2025cites this paper
• Integrative human atrial modelling unravels interactive protein kinase A and Ca2+/calmodulin-dependent protein kinase II signalling as key determinants of atrial arrhythmogenesis

  2022cites this paper
• Stress-driven cardiac calcium mishandling via a kinase-to-kinase crosstalk

  2021cites this paper
• Computational modeling approaches to cAMP/PKA signaling in cardiomyocytes.

  2021cites this paper
• Cellular Mechanisms of the Anti-Arrhythmic Effect of Cardiac PDE2 Overexpression

  2021cites this paper
• Function and regulation of phosphatase 1 in healthy and diseased heart.

  2021cites this paper
• Cardiomyocyte calcium handling in health and disease: Insights from in vitro and in silico studies.

  2020cites this paper
• EPAC Proteins and Their Role in the Physiological and Pathological Processes in the Cardiovascular System. Part II. The role of EPAC Proteins in the Physiology and Pathology of the Heart

  2020cites this paper
• EPAC Proteins and Their Role in the Physiological and Pathological Processes in the Cardiovascular System. Part II. The role of EPAC Proteins in the Physiology and Pathology of the Heart

  2020cites this paper
• Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy

  2020cites this paper
• Ca2+/Calmodulin-Dependent Protein Kinase II Regulation by Inhibitor 1 of Protein Phosphatase 1 Protects Against Myocardial Ischemia–Reperfusion Injury

  2019cites this paper
• Functions and therapeutic potential of protein phosphatase 1: Insights from mouse genetics

  2018cites this paper